Back
Valhi, Inc. 10K Form
Sell
48
VHI
Valhi, Inc.
Last Price:
$12.43
Seasonality Move:
28.37%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | VHI/Valhi, Inc. Quarterly |
| 2023-11-06 | 10Q | VHI/Valhi, Inc. Quarterly |
| 2023-08-03 | 10Q | VHI/Valhi, Inc. Quarterly |
| 2023-05-04 | 10Q | VHI/Valhi, Inc. Quarterly |
| 2022-11-03 | 10Q | VHI/Valhi, Inc. Quarterly |
| 2022-08-04 | 10Q | VHI/Valhi, Inc. Quarterly |
Receive VHI News And Ratings
See the #1 stock for the next 7 days that we like better than VHI
VHI Financial Statistics
Sales & Book Value
| Annual Sales: | $2.1B |
|---|---|
| Cash Flow: | $-12.3M |
| Price / Cash Flow: | 38.18 |
| Annual Sales: | $37.01 |
| Price / Book: | 0.35 |
Profitability
| EPS (TTM): | 0.64560 |
|---|---|
| Net Income (TTM): | $40.8M |
| Gross Margin: | $426.5M |
| Return on Equity: | 2.92% |
| Return on Assets: | 1.48% |
Valhi, Inc. Earnings Forecast
Key Valhi, Inc. Financial Ratios
-
The Gross Profit Margin over the past 40 years for VHI is 20.26%.
-
The Selling, General & Administrative Expenses for VHI have been equal to 12.17% of Gross Profit Margin.
-
The Research & Development expenses have been 0.67% of Revenue.
-
The Interest Expense is 30.94% of Operating Income.
-
The Net Earning history of VHI is 7.66% of Total Revenues.
-
Per Share Earnings over the last 40 years have been positive in 19 years.
Valhi, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Chemicals |
| Sector: | Materials |
| Current Symbol: | VHI |
| CUSIP: | 918905 |
| Website: | valhi.net |
Debt
| Debt-to-Equity Ratio: | 0.65 |
|---|---|
| Current Ratio: | 3.64 |
| Quick Ratio: | 1.52 |
Price-to-Earnings
| Trailing P/E Ratio: | 3.45 |
|---|---|
| Forward P/E Ratio: | 4.55 |
VHI Technical Analysis vs Fundamental Analysis
Sell
48
Valhi, Inc. (VHI)
is a Sell
Is Valhi, Inc. a Buy or a Sell?
-
Valhi, Inc. stock is rated a SellThe current Valhi, Inc. [VHI] share price is $12.29. The Score for VHI is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.